| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NEBL CENPE KIF21A KTN1 CEP290 NUMA1 MAP3K1 CCDC88C CDK5R1 PTPRC BRCA2 SYNE2 KIF14 MACF1 ROCK1 CTTN CAMSAP2 NOS2 PLS3 TBCC | 2.17e-07 | 1099 | 96 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 6.58e-07 | 15 | 96 | 4 | GO:0051011 | |
| GeneOntologyMolecularFunction | tubulin binding | CENPE KIF21A CEP290 NUMA1 CCDC88C CDK5R1 BRCA2 KIF14 MACF1 CAMSAP2 TBCC | 6.63e-06 | 428 | 96 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | 1.20e-04 | 308 | 96 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.61e-04 | 70 | 96 | 4 | GO:0003777 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SEMG1 RIPOR2 CENPE CCDC146 IFT172 KIF21A KTN1 CEP290 NUMA1 CCDC88C CDK5R1 CEP120 BRCA2 SYNE2 KIF14 MACF1 ROCK1 CAMSAP2 DNAH11 | 2.91e-07 | 1058 | 95 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | SEMG1 RIPOR2 NUMA1 CCDC88C CDK5R1 CEP120 MACF1 ROCK1 CAMSAP2 DNAH11 | 1.00e-06 | 293 | 95 | 10 | GO:0032886 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | RIPOR2 CENPE CCDC146 IFT172 CEP290 NUMA1 CCDC88C CDK5R1 CEP120 BRCA2 SYNE2 KIF14 ROCK1 CAMSAP2 | 5.25e-06 | 720 | 95 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 1.33e-05 | 66 | 95 | 5 | GO:0031122 | |
| GeneOntologyBiologicalProcess | actin filament-based process | IQSEC3 SCN11A DSC2 NEBL MAP3K1 GPD1L CCDC88C CDK5R1 SYNE2 PCDH15 ROCK1 TTC17 POTEJ CTTN PLS3 | 1.74e-05 | 912 | 95 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell projection assembly | RIPOR2 CCDC146 DOCK11 IFT172 CEP290 TSGA10 CEP120 SYNE2 PCDH15 ROCK1 VAV3 CTTN | 7.19e-05 | 685 | 95 | 12 | GO:0030031 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 7.62e-05 | 153 | 95 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | SEMG1 CENPE CCDC146 IFT172 KIF21A KTN1 CCDC88C SYNE2 KIF14 DNAH11 | 9.13e-05 | 493 | 95 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | NEBL IFT172 NUMA1 MAP3K1 CCDC88C CDK5R1 CEP120 PCDH15 KIF14 ROCK1 TTC17 CTTN CAMSAP2 PLS3 | 1.20e-04 | 957 | 95 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 1.64e-04 | 176 | 95 | 6 | GO:0070507 | |
| GeneOntologyBiologicalProcess | apical constriction | 2.08e-04 | 5 | 95 | 2 | GO:0003383 | |
| GeneOntologyCellularComponent | microtubule organizing center | FAM184A HK2 CCDC146 BCAS2 IFT172 CTSC CEP290 NUMA1 TSGA10 ANKRD26 ANKRD62 MCM3 CCDC178 CCDC88C CEP120 BRCA2 CEP112 ROCK1 CAMSAP2 | 3.14e-08 | 919 | 96 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | FAM184A HK2 CCDC146 BCAS2 CTSC CEP290 NUMA1 ANKRD26 ANKRD62 MCM3 CCDC88C CEP120 BRCA2 CEP112 CAMSAP2 | 2.22e-06 | 770 | 96 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | spindle midzone | 3.36e-05 | 40 | 96 | 4 | GO:0051233 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 5.03e-05 | 16 | 96 | 3 | GO:1990023 | |
| GeneOntologyCellularComponent | supramolecular fiber | NEBL CENPE KIF21A NUMA1 ZNF804A MAP3K1 CDK5R1 SYNE2 KIF14 MACF1 POTEJ CTTN CAMSAP2 PLS3 TBCC DNAH11 | 8.77e-05 | 1179 | 96 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NEBL CENPE KIF21A NUMA1 ZNF804A MAP3K1 CDK5R1 SYNE2 KIF14 MACF1 POTEJ CTTN CAMSAP2 PLS3 TBCC DNAH11 | 9.50e-05 | 1187 | 96 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CENPE KIF21A NUMA1 ZNF804A MAP3K1 KIF14 MACF1 POTEJ CTTN CAMSAP2 PLS3 TBCC DNAH11 | 2.34e-04 | 899 | 96 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule minus-end | 4.32e-04 | 7 | 96 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | microtubule | 7.73e-04 | 533 | 96 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 9.17e-04 | 10 | 96 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | bleb | 9.17e-04 | 10 | 96 | 2 | GO:0032059 | |
| GeneOntologyCellularComponent | centriole | 1.19e-03 | 172 | 96 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.33e-03 | 576 | 96 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.34e-03 | 12 | 96 | 2 | GO:0031074 | |
| Domain | - | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 3.70e-06 | 248 | 92 | 9 | 1.25.40.20 |
| Domain | ANK | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 4.08e-06 | 251 | 92 | 9 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 4.35e-06 | 253 | 92 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 4.49e-06 | 254 | 92 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 4.49e-06 | 254 | 92 | 9 | PS50297 |
| Domain | Ankyrin_rpt | POTEB3 POTEG ANKRD26 ANKRD62 ANKRD30B POTEM ANKRD30A POTEJ POTEH | 5.77e-06 | 262 | 92 | 9 | IPR002110 |
| Domain | Ank_2 | 1.10e-05 | 215 | 92 | 8 | PF12796 | |
| Domain | Ank | 1.68e-05 | 228 | 92 | 8 | PF00023 | |
| Domain | - | 2.62e-05 | 71 | 92 | 5 | 1.10.418.10 | |
| Domain | CH | 3.00e-05 | 73 | 92 | 5 | PS50021 | |
| Domain | CH-domain | 3.42e-05 | 75 | 92 | 5 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 1.91e-04 | 23 | 92 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 1.91e-04 | 23 | 92 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.91e-04 | 23 | 92 | 3 | PS00019 | |
| Domain | CH | 2.97e-04 | 65 | 92 | 4 | SM00033 | |
| Domain | CH | 3.94e-04 | 70 | 92 | 4 | PF00307 | |
| Domain | Arm_3 | 4.96e-04 | 7 | 92 | 2 | PF16186 | |
| Domain | CAMSAP_CH | 4.96e-04 | 7 | 92 | 2 | PF11971 | |
| Domain | Importing_su_alpha | 4.96e-04 | 7 | 92 | 2 | IPR024931 | |
| Domain | Arm_3 | 4.96e-04 | 7 | 92 | 2 | IPR032413 | |
| Domain | CAMSAP_CH | 4.96e-04 | 7 | 92 | 2 | IPR022613 | |
| Domain | IBB | 4.96e-04 | 7 | 92 | 2 | PF01749 | |
| Domain | IBB | 6.59e-04 | 8 | 92 | 2 | PS51214 | |
| Domain | Importin-a_IBB | 8.45e-04 | 9 | 92 | 2 | IPR002652 | |
| Domain | Kinesin_motor_CS | 1.08e-03 | 41 | 92 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.24e-03 | 43 | 92 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.32e-03 | 44 | 92 | 3 | PS00411 | |
| Domain | - | 1.32e-03 | 44 | 92 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.32e-03 | 44 | 92 | 3 | IPR001752 | |
| Domain | Kinesin | 1.32e-03 | 44 | 92 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.32e-03 | 44 | 92 | 3 | PS50067 | |
| Domain | KISc | 1.32e-03 | 44 | 92 | 3 | SM00129 | |
| Domain | ARM-type_fold | 1.43e-03 | 339 | 92 | 7 | IPR016024 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 5.11e-05 | 42 | 69 | 4 | MM15677 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 6.16e-05 | 44 | 69 | 4 | MM15678 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CENPE ZCCHC8 POLDIP3 ZNF180 ANKRD26 MCM3 DNAJC7 DIS3 BRCA2 KIF14 MACF1 ROCK1 POTEJ DOT1L CNOT3 | 9.55e-11 | 588 | 97 | 15 | 38580884 |
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 16364570 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FAM184A CENPE CEP290 ANKRD26 MCM3 FCHO2 DNAJC7 CCDC88C CEP120 BRCA2 KIF14 TTC17 CTTN CAMSAP2 PLS3 | 1.48e-08 | 853 | 97 | 15 | 28718761 |
| Pubmed | IQSEC3 CENPE DOCK11 KIF21A KTN1 NUMA1 MCM3 SMC2 CCDC88C SYNE2 MACF1 ROCK1 CTTN CAMSAP2 GOLGA4 | 7.23e-08 | 963 | 97 | 15 | 28671696 | |
| Pubmed | KPNA4 SCN11A KIF21A KTN1 NUMA1 ANKRD26 CCDC150 ANKRD30B SMC2 DNAJC7 CEP112 SYNE2 ANKRD30A MACF1 POTEJ CTTN CAMSAP2 CCDC191 | 8.82e-08 | 1442 | 97 | 18 | 35575683 | |
| Pubmed | DSC2 KTN1 NUMA1 ANKRD26 MCM3 FCHO2 SMC2 DNAJC7 MACF1 ROCK1 CTTN PLS3 GOLGA4 | 8.98e-08 | 708 | 97 | 13 | 39231216 | |
| Pubmed | POLR1A NEBL CENPE POLDIP3 KTN1 CEP290 RNF213 GPATCH8 KIF14 ROCK1 FAM3C TTC17 GOLGA4 | 1.34e-07 | 733 | 97 | 13 | 34672954 | |
| Pubmed | EXPH5 KTN1 CEP290 ANKRD26 ANKRD62 RNF213 RUFY2 GPD1L CCDC88C MACF1 CNOT3 | 1.38e-07 | 493 | 97 | 11 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KPNA4 POLR1A CENPE DOCK11 EXPH5 KTN1 NUMA1 DNAJC7 TRRAP CTTN ZNF99 | 1.50e-07 | 497 | 97 | 11 | 36774506 |
| Pubmed | 2.66e-07 | 20 | 97 | 4 | 21689717 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 17171436 | ||
| Pubmed | HK2 ZCCHC8 POLDIP3 BCAS2 KTN1 NUMA1 RNF213 MCM3 FCHO2 SMC2 DNAJC7 DIS3 SYNE2 KIF14 CTTN PLS3 CNOT3 | 4.61e-07 | 1440 | 97 | 17 | 30833792 | |
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 15276201 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 12475935 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.37e-06 | 498 | 97 | 10 | 36634849 | |
| Pubmed | KPNA4 BCAS2 CTSC KIF21A NUMA1 NCSTN DNAJC7 TRRAP CEP112 SYNE2 MACF1 FAM3C TTC17 PLS3 CNOT3 | 3.05e-06 | 1297 | 97 | 15 | 33545068 | |
| Pubmed | 3.26e-06 | 549 | 97 | 10 | 38280479 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 3.50e-06 | 37 | 97 | 4 | 27565344 | |
| Pubmed | 3.92e-06 | 327 | 97 | 8 | 31409639 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.09e-06 | 440 | 97 | 9 | 34244565 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DSC2 DOCK11 ZCCHC8 EXPH5 ANKRD26 CCDC88C CEP112 SYNE2 KIF14 MACF1 CAMSAP2 GOLGA4 | 5.10e-06 | 861 | 97 | 12 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | POLR1A POLDIP3 BCAS2 CEP290 NUMA1 MCM3 SMC2 DNAJC7 TRRAP SYNE2 KIF14 MACF1 CTTN | 5.49e-06 | 1024 | 97 | 13 | 24711643 |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15265687 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21842266 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28266632 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11280766 | ||
| Pubmed | A novel form of ciliopathy underlies hyperphagia and obesity in Ankrd26 knockout mice. | 7.70e-06 | 2 | 97 | 2 | 24633808 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KPNA4 HK2 BCAS2 KIF21A KTN1 NUMA1 MCM3 SMC2 DNAJC7 DIS3 SYNE2 MACF1 CTTN PLS3 GOLGA4 | 8.67e-06 | 1415 | 97 | 15 | 28515276 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1A CENPE POLDIP3 BCAS2 KTN1 NUMA1 SMC2 TRRAP MAP3K1 MACF1 SGO2 | 9.02e-06 | 759 | 97 | 11 | 35915203 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 9.34e-06 | 15 | 97 | 3 | 16824795 | |
| Pubmed | KPNA4 NEBL POLDIP3 KIF21A KTN1 NUMA1 MCM3 SMC2 DNAJC7 DIS3 DOT1L CTTN CAMSAP2 CNOT3 | 9.41e-06 | 1247 | 97 | 14 | 27684187 | |
| Pubmed | 1.62e-05 | 660 | 97 | 10 | 32780723 | ||
| Pubmed | 1.91e-05 | 116 | 97 | 5 | 21282530 | ||
| Pubmed | 2.00e-05 | 57 | 97 | 4 | 29089450 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25176644 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20809358 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21305317 | ||
| Pubmed | Genome-wide identification of mouse congenital heart disease loci. | 2.31e-05 | 3 | 97 | 2 | 20511334 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 POLR1A RASA3 POLDIP3 BCAS2 KIF21A KTN1 NUMA1 MCM3 SMC2 TRRAP DIS3 MACF1 GOLGA4 | 2.33e-05 | 1353 | 97 | 14 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | POLR1A KIF21A NUMA1 MCM3 SMC2 DNAJC7 ZNF804A MACF1 ROCK1 CTTN PLS3 | 2.48e-05 | 847 | 97 | 11 | 35235311 |
| Pubmed | POLR1A POLDIP3 BCAS2 NUMA1 RNF213 MCM3 GPATCH8 SMC2 DNAJC7 TRRAP DIS3 CTTN | 2.59e-05 | 1014 | 97 | 12 | 32416067 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.68e-05 | 208 | 97 | 6 | 33230847 | |
| Pubmed | K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. | 3.38e-05 | 65 | 97 | 4 | 29378950 | |
| Pubmed | KPNA4 BCAS2 CEP290 RNF213 FCHO2 DNAJC7 PTPRC SYNE2 PPM1L KIF14 ROCK1 GOLGA4 | 3.60e-05 | 1049 | 97 | 12 | 27880917 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 POLR1A POLDIP3 KTN1 NUMA1 MCM3 SMC2 DNAJC7 DIS3 KIF14 SGO2 CTTN PLS3 GOLGA4 | 4.10e-05 | 1425 | 97 | 14 | 30948266 |
| Pubmed | Shugoshin-2 is essential for the completion of meiosis but not for mitotic cell division in mice. | 4.60e-05 | 4 | 97 | 2 | 18765791 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19306359 | ||
| Pubmed | Centriole signaling restricts hepatocyte ploidy to maintain liver integrity. | 4.60e-05 | 4 | 97 | 2 | 35981754 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15601830 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 24143212 | ||
| Pubmed | Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes. | 4.60e-05 | 4 | 97 | 2 | 22184201 | |
| Pubmed | KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. | 4.60e-05 | 4 | 97 | 2 | 15897902 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 12610148 | ||
| Pubmed | Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts. | 4.60e-05 | 4 | 97 | 2 | 21669876 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 9395085 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 17342726 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23707952 | ||
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 5.22e-05 | 26 | 97 | 3 | 25820252 | |
| Pubmed | 5.46e-05 | 472 | 97 | 8 | 38943005 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NEBL ZCCHC8 POLDIP3 KTN1 PARG NUMA1 ANKRD26 DIS3 MACF1 CTTN CAMSAP2 | 6.00e-05 | 934 | 97 | 11 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZCCHC8 PARG NUMA1 MCM3 GPATCH8 TRRAP PTPRC CTTN CNOT3 GOLGA4 | 6.19e-05 | 774 | 97 | 10 | 15302935 |
| Pubmed | 6.69e-05 | 486 | 97 | 8 | 20936779 | ||
| Pubmed | KPNA4 FAM184A POLR1A NEBL ZCCHC8 BCAS2 KTN1 GPATCH8 TRRAP KIF14 MACF1 CAMSAP2 PLS3 CNOT3 | 6.96e-05 | 1497 | 97 | 14 | 31527615 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 7.31e-05 | 363 | 97 | 7 | 14691545 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 18355772 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 19961612 | ||
| Pubmed | Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. | 7.66e-05 | 5 | 97 | 2 | 17981117 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 26933822 | ||
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 7.66e-05 | 5 | 97 | 2 | 22705394 | |
| Pubmed | 8.85e-05 | 506 | 97 | 8 | 30890647 | ||
| Pubmed | KPNA4 KPNA5 POLDIP3 BCAS2 NCSTN SMC2 DNAJC7 MACF1 POTEJ TBR1 DCBLD2 PLS3 | 8.88e-05 | 1153 | 97 | 12 | 29845934 | |
| Pubmed | 9.03e-05 | 653 | 97 | 9 | 22586326 | ||
| Pubmed | 9.68e-05 | 163 | 97 | 5 | 24316575 | ||
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 9.84e-05 | 32 | 97 | 3 | 27437069 | |
| Pubmed | HK2 CENPE CTSC KTN1 CEP290 RNF213 MCM3 NCSTN DNAJC7 DIS3 PTPRC KIF14 | 1.00e-04 | 1168 | 97 | 12 | 19946888 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.04e-04 | 665 | 97 | 9 | 30457570 | |
| Pubmed | Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. | 1.15e-04 | 6 | 97 | 2 | 8551560 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 22666460 | ||
| Pubmed | Modulation of p53 function by SET8-mediated methylation at lysine 382. | 1.15e-04 | 6 | 97 | 2 | 17707234 | |
| Pubmed | Breast cancer susceptibility variants alter risks in familial disease. | 1.15e-04 | 6 | 97 | 2 | 19617217 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 2064827 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9548947 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9557700 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9603322 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9593140 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 7585960 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 8041786 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 8041734 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9303297 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 11904219 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 9918876 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 7859280 | ||
| Pubmed | Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. | 1.15e-04 | 6 | 97 | 2 | 8529100 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 28594961 | ||
| Pubmed | Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. | 1.15e-04 | 6 | 97 | 2 | 9008157 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 15037073 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 8876228 | ||
| Pubmed | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. | 1.15e-04 | 6 | 97 | 2 | 7745752 | |
| Pubmed | Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. | 1.15e-04 | 6 | 97 | 2 | 8659115 | |
| Pubmed | 1.15e-04 | 169 | 97 | 5 | 31462741 | ||
| Interaction | NINL interactions | FAM184A CENPE CCDC146 CEP290 ANKRD26 CCDC172 SMC2 CCDC88C BRCA2 KIF14 TTC17 CAMSAP2 PLS3 CNOT3 | 4.03e-08 | 458 | 97 | 14 | int:NINL |
| Interaction | KCNA3 interactions | DSC2 CCDC73 EXPH5 KTN1 NUMA1 ANKRD26 RNF213 MCM3 FCHO2 SMC2 DNAJC7 CCDC88C CEP112 MACF1 ROCK1 CTTN PLS3 GOLGA4 | 1.56e-07 | 871 | 97 | 18 | int:KCNA3 |
| Interaction | NDC80 interactions | CENPE CEP290 ANKRD26 DNAJC7 ESCO2 SYNE2 KIF14 ROCK1 CTTN CAMSAP2 | 2.62e-06 | 312 | 97 | 10 | int:NDC80 |
| Interaction | PCM1 interactions | FAM184A NEBL CENPE IFT172 CEP290 ANKRD26 CCDC172 CEP120 CEP112 KIF14 CAMSAP2 | 7.68e-06 | 434 | 97 | 11 | int:PCM1 |
| Interaction | NIN interactions | FAM184A CENPE CEP290 ANKRD26 MCM3 BRCA2 KIF14 DOT1L CTTN CAMSAP2 | 9.03e-06 | 359 | 97 | 10 | int:NIN |
| Interaction | SYNE3 interactions | KPNA5 CENPE EXPH5 ANKRD26 NCSTN MINPP1 BRCA2 SYNE2 KIF14 MACF1 TTC17 | 9.51e-06 | 444 | 97 | 11 | int:SYNE3 |
| Interaction | POTEH interactions | 2.29e-05 | 2 | 97 | 2 | int:POTEH | |
| Interaction | YWHAE interactions | DSC2 MLX CENPE DOCK11 EXPH5 KTN1 ANKRD26 SMC2 MAP3K1 CCDC88C CEP112 KIF14 MACF1 ROCK1 TTC17 DOT1L CAMSAP2 NOS2 | 2.71e-05 | 1256 | 97 | 18 | int:YWHAE |
| Interaction | PLEC interactions | 4.24e-05 | 430 | 97 | 10 | int:PLEC | |
| Interaction | TRIM52 interactions | 4.46e-05 | 133 | 97 | 6 | int:TRIM52 | |
| Interaction | FBXO22 interactions | KPNA4 POLR1A CENPE DOCK11 EXPH5 KTN1 NUMA1 DNAJC7 TRRAP CTTN ZNF99 | 5.73e-05 | 540 | 97 | 11 | int:FBXO22 |
| Interaction | EZR interactions | NEBL POLDIP3 PARG ANKRD26 FCHO2 PTPRC KIF14 MACF1 ROCK1 TBR1 PLS3 | 7.09e-05 | 553 | 97 | 11 | int:EZR |
| Interaction | CXADR interactions | 7.27e-05 | 369 | 97 | 9 | int:CXADR | |
| Interaction | TXNIP interactions | 7.44e-05 | 212 | 97 | 7 | int:TXNIP | |
| Interaction | NHLRC2 interactions | 8.22e-05 | 375 | 97 | 9 | int:NHLRC2 | |
| Interaction | MIB1 interactions | 8.97e-05 | 295 | 97 | 8 | int:MIB1 | |
| Interaction | RAC2 interactions | DSC2 RASA3 DOCK11 KTN1 FCHO2 TRRAP SYNE2 KIF14 MACF1 ROCK1 NOS2 GOLGA4 | 9.42e-05 | 674 | 97 | 12 | int:RAC2 |
| Interaction | NUP155 interactions | 1.00e-04 | 477 | 97 | 10 | int:NUP155 | |
| Interaction | DCTN1 interactions | NEBL CENPE CEP290 MCM3 SMC2 CCDC88C KIF14 MACF1 DOT1L CAMSAP2 | 1.40e-04 | 497 | 97 | 10 | int:DCTN1 |
| Interaction | SMC3 interactions | 1.55e-04 | 408 | 97 | 9 | int:SMC3 | |
| Interaction | LOXL2 interactions | 1.61e-04 | 410 | 97 | 9 | int:LOXL2 | |
| Interaction | YWHAZ interactions | RIPOR2 DSC2 MLX DOCK11 EXPH5 ANKRD26 SMC2 DNAJC7 MAP3K1 CCDC88C KMT5B CEP112 SYNE2 KIF14 MACF1 CAMSAP2 NOS2 | 1.71e-04 | 1319 | 97 | 17 | int:YWHAZ |
| Interaction | ZMYM4 interactions | 1.78e-04 | 171 | 97 | 6 | int:ZMYM4 | |
| Interaction | MAPRE1 interactions | KPNA4 CENPE KTN1 CEP290 NUMA1 ANKRD26 KIF14 MACF1 CTTN CAMSAP2 | 1.84e-04 | 514 | 97 | 10 | int:MAPRE1 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.19e-08 | 13 | 61 | 4 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.47e-06 | 242 | 61 | 8 | 403 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.00e-04 | 46 | 61 | 3 | 622 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.65e-03 | 18 | 61 | 2 | 596 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.26e-03 | 21 | 61 | 2 | 980 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.48e-03 | 22 | 61 | 2 | 579 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.15e-03 | 206 | 61 | 4 | 682 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.86e-03 | 34 | 61 | 2 | 487 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 8.53e-08 | 12 | 97 | 4 | M34000 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 3.16e-06 | 322 | 97 | 9 | M39060 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.13e-06 | 426 | 97 | 10 | M9516 | |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_6HR_DN | 4.25e-06 | 114 | 97 | 6 | M2590 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 4.89e-06 | 180 | 97 | 7 | M2961 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 5.45e-06 | 183 | 97 | 7 | M2993 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPE BCAS2 KTN1 CEP290 C1GALT1 SMC2 DNAJC7 CEP112 SYNE2 KIF14 PLS3 GOLGA4 | 5.60e-06 | 656 | 97 | 12 | M18979 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 6.29e-06 | 187 | 97 | 7 | M2984 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 6.79e-06 | 354 | 97 | 9 | M39061 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.46e-05 | 155 | 97 | 6 | M39041 | |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 2.79e-05 | 95 | 97 | 5 | M18506 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CENPE MCM3 SMC2 KCNB2 DIS3 CDK5R1 BRCA2 KIF14 SGO2 DOT1L DCBLD2 | 4.35e-05 | 680 | 97 | 11 | MM456 |
| Coexpression | KOYAMA_SEMA3B_TARGETS_UP | 6.34e-05 | 268 | 97 | 7 | M12746 | |
| Coexpression | EGUCHI_CELL_CYCLE_RB1_TARGETS | 7.19e-05 | 22 | 97 | 3 | M4455 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN | 7.33e-05 | 60 | 97 | 4 | M4856 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE PARG GPATCH8 TRRAP ZNF804A BRCA2 SYNE2 KIF14 MACF1 ROCK1 CAMSAP2 GOLGA4 | 7.62e-05 | 856 | 97 | 12 | M4500 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 7.67e-05 | 190 | 97 | 6 | M761 | |
| Coexpression | GEORGES_CELL_CYCLE_MIR192_TARGETS | 8.34e-05 | 62 | 97 | 4 | M11038 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN | 8.85e-05 | 195 | 97 | 6 | M7410 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN | 8.88e-05 | 63 | 97 | 4 | MM591 | |
| Coexpression | GSE6875_TCONV_VS_FOXP3_KO_TREG_UP | 9.62e-05 | 198 | 97 | 6 | M6801 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 1.02e-04 | 200 | 97 | 6 | M5746 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | KPNA5 CENPE MCM3 SMC2 CCDC7 ESCO2 BRCA2 KIF14 MACF1 SGO2 DCBLD2 PLS3 | 1.12e-04 | 892 | 97 | 12 | M18120 |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.20e-04 | 68 | 97 | 4 | M41108 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.28e-04 | 300 | 97 | 7 | M39059 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.40e-04 | 212 | 97 | 6 | M39221 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.42e-04 | 305 | 97 | 7 | M19875 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | KPNA5 RIPOR2 MLX KTN1 CEP290 NUMA1 GPD1L SYNE2 MACF1 ROCK1 FAM3C RNF139 GOLGA4 TBCC | 1.50e-04 | 1215 | 97 | 14 | M41122 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 1.53e-04 | 309 | 97 | 7 | MM1244 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | HK2 CTSC TRRAP CDK5R1 PTPRC SYNE2 KIF14 MACF1 CTTN RNF139 CAMSAP2 | 1.64e-04 | 790 | 97 | 11 | M12490 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CENPE ZCCHC8 ANKRD26 MCM3 SMC2 MAP3K1 ESCO2 CEP120 BRCA2 SYNE2 KIF14 SGO2 | 1.81e-04 | 939 | 97 | 12 | M45768 |
| Coexpression | ZHONG_PFC_C1_OPC | 2.61e-04 | 238 | 97 | 6 | M39096 | |
| Coexpression | DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 2.85e-04 | 242 | 97 | 6 | M34034 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPE DOCK11 KIF21A KTN1 PARG CEP290 ANKRD26 C1GALT1 SMC2 BRCA2 KIF14 SGO2 ROCK1 | 8.01e-07 | 532 | 96 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.05e-06 | 186 | 96 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPE IFT172 KIF21A ZNF180 CEP290 NUMA1 ANKRD26 SMC2 RUFY2 BRCA2 SYNE2 MACF1 ROCK1 CTTN ZNF99 | 2.15e-06 | 780 | 96 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.60e-06 | 192 | 96 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.60e-06 | 192 | 96 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | FAM184A HK2 CENPE KIF21A KTN1 CEP290 TSGA10 ANKRD26 C1GALT1 SMC2 RUFY2 ESCO2 CCDC88C CEP120 BRCA2 SYNE2 MACF1 SGO2 ROCK1 | 2.95e-06 | 1257 | 96 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.25e-06 | 139 | 96 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | FAM184A NEBL CENPE KIF21A KTN1 CEP290 TSGA10 ANKRD26 GPATCH8 SMC2 RUFY2 ESCO2 CCDC88C BRCA2 CEP112 SYNE2 PPM1L KIF14 CCDC191 | 1.02e-05 | 1370 | 96 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CENPE KIF21A KTN1 CEP290 TSGA10 ANKRD26 CCDC88C BRCA2 SYNE2 ROCK1 GOLGA4 | 1.55e-05 | 498 | 96 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | CCDC73 KIF21A PARG CCDC150 RNF213 CCDC172 GPATCH8 DIS3 ESCO2 BRCA2 KIF14 SGO2 FAM3C CCDC191 | 1.62e-05 | 810 | 96 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAM184A CENPE KIF21A ZNF180 KTN1 CEP290 NUMA1 ANKRD26 BRCA2 SYNE2 PPM1L CTTN ZNF99 GOLGA4 | 2.15e-05 | 831 | 96 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | FAM184A HK2 CENPE KIF21A KTN1 CEP290 TSGA10 ANKRD26 C1GALT1 SMC2 RUFY2 ESCO2 CCDC88C CEP120 BRCA2 SYNE2 MACF1 SGO2 ROCK1 | 2.46e-05 | 1459 | 96 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.24e-05 | 298 | 96 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DSC2 CENPE DOCK11 CEP290 ANKRD26 RNF213 MCM3 SMC2 MAP3K1 ESCO2 SYNE2 ROCK1 CTTN | 6.62e-05 | 804 | 96 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RIPOR2 POLR1A CENPE DOCK11 RNF213 MCM3 SMC2 MAP3K1 ESCO2 SYNE2 ROCK1 CTTN CNOT3 | 6.79e-05 | 806 | 96 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CENPE KIF21A CEP290 ANKRD26 C1GALT1 SMC2 BRCA2 SYNE2 MACF1 ROCK1 | 7.73e-05 | 492 | 96 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | FAM184A RIPOR2 CENPE KIF21A CEP290 TSGA10 ANKRD26 SMC2 CCDC88C BRCA2 SYNE2 PPM1L KIF14 MACF1 SGO2 | 7.92e-05 | 1060 | 96 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.40e-05 | 311 | 96 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 8.67e-05 | 402 | 96 | 9 | GSM791105_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.11e-05 | 233 | 96 | 7 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 1.14e-04 | 417 | 96 | 9 | GSM399403_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.43e-04 | 110 | 96 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CENPE CTSC KIF21A CEP290 TSGA10 ANKRD26 C1GALT1 FCHO2 SMC2 RUFY2 ESCO2 CEP120 BRCA2 SYNE2 SGO2 ROCK1 | 1.47e-04 | 1252 | 96 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.59e-04 | 255 | 96 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | RIPOR2 HK2 POLR1A DSC2 KIF21A RNF213 NCSTN MINPP1 TRRAP MAP3K1 SYNE2 PPM1L CTTN | 1.63e-04 | 880 | 96 | 13 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FAM184A RIPOR2 CENPE KIF21A CEP290 TSGA10 ANKRD26 SMC2 ZNF804A CCDC88C BRCA2 SYNE2 PPM1L KIF14 MACF1 SGO2 NOS2 | 1.85e-04 | 1414 | 96 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 2.71e-04 | 69 | 96 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.75e-04 | 469 | 96 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | 2.85e-04 | 372 | 96 | 8 | GSM538204_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | BCAS2 PARG CCDC150 RNF213 MCM3 CCDC172 DIS3 ESCO2 BRCA2 KIF14 SGO2 CCDC191 | 3.30e-04 | 822 | 96 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.56e-04 | 291 | 96 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 3.78e-04 | 388 | 96 | 8 | GSM538352_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 3.90e-04 | 492 | 96 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | FAM184A HK2 NEBL CENPE KIF21A KTN1 ANKRD26 MCM3 GPATCH8 SMC2 DIS3 CCDC88C BRCA2 PPM1L SGO2 DCBLD2 | 4.09e-04 | 1371 | 96 | 16 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.10e-04 | 138 | 96 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.10e-04 | 298 | 96 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 4.33e-04 | 396 | 96 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 4.48e-04 | 398 | 96 | 8 | GSM399397_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 4.55e-04 | 399 | 96 | 8 | GSM538345_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 4.83e-04 | 143 | 96 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FAM184A CENPE KIF21A KTN1 CEP290 TSGA10 ANKRD26 CCDC88C BRCA2 SYNE2 PPM1L ROCK1 GOLGA4 | 5.02e-04 | 989 | 96 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CENPE DOCK11 CTSC KIF21A KTN1 CEP290 RNF213 FCHO2 SMC2 BRCA2 SYNE2 MACF1 ROCK1 | 5.02e-04 | 989 | 96 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 5.36e-04 | 409 | 96 | 8 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 5.44e-04 | 410 | 96 | 8 | GSM791122_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 6.52e-04 | 232 | 96 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 7.45e-04 | 90 | 96 | 4 | GSM399397_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DOCK11 CEP290 ANKRD26 RNF213 MCM3 CCDC172 SMC2 ESCO2 BRCA2 SYNE2 ROCK1 | 7.56e-04 | 776 | 96 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 8.26e-04 | 161 | 96 | 5 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.84e-04 | 246 | 96 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.99e-04 | 168 | 96 | 5 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 1.02e-03 | 98 | 96 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 1.04e-03 | 349 | 96 | 7 | GSM476675_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 1.11e-03 | 45 | 96 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_200 | |
| CoexpressionAtlas | B cells, B.T1.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23-, Spleen, avg-3 | 1.11e-03 | 353 | 96 | 7 | GSM538213_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | CENPE DOCK11 CEP290 ANKRD26 MCM3 SMC2 ZNF804A ESCO2 SYNE2 ROCK1 CTTN | 1.13e-03 | 815 | 96 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CCDC73 PARG ANKRD26 CCDC150 CCDC172 GPATCH8 ESCO2 BRCA2 KIF14 SGO2 CCDC191 | 1.18e-03 | 820 | 96 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.39e-03 | 474 | 96 | 8 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_1000 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-09 | 180 | 97 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.53e-09 | 191 | 97 | 8 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.53e-09 | 191 | 97 | 8 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.12e-08 | 195 | 97 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.17e-08 | 196 | 97 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.21e-08 | 197 | 97 | 8 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.21e-08 | 197 | 97 | 8 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-08 | 197 | 97 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.21e-08 | 197 | 97 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.26e-08 | 198 | 97 | 8 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.26e-08 | 198 | 97 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-08 | 198 | 97 | 8 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.31e-08 | 199 | 97 | 8 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.31e-08 | 199 | 97 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating-Cycling|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 322337a5a9cc2de1913ee9258c98ae51fb4bd6bb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | c784459a62bebec560e79aba83de8611457437bc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-08 | 163 | 97 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.00e-08 | 169 | 97 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-08 | 170 | 97 | 7 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 176 | 97 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 178 | 97 | 7 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 178 | 97 | 7 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-07 | 181 | 97 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 182 | 97 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.49e-07 | 182 | 97 | 7 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.55e-07 | 183 | 97 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-07 | 183 | 97 | 7 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.67e-07 | 185 | 97 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-07 | 187 | 97 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.93e-07 | 189 | 97 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 97 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 2.00e-07 | 190 | 97 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.07e-07 | 191 | 97 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 2.07e-07 | 191 | 97 | 7 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.07e-07 | 191 | 97 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 2.07e-07 | 191 | 97 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Cycling_DC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.07e-07 | 191 | 97 | 7 | 1da569ebcfab4e1a95315430ae77a17a1f119263 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.30e-07 | 194 | 97 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 2.30e-07 | 194 | 97 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.30e-07 | 194 | 97 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 2.30e-07 | 194 | 97 | 7 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.30e-07 | 194 | 97 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.30e-07 | 194 | 97 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-07 | 195 | 97 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-07 | 195 | 97 | 7 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 2.38e-07 | 195 | 97 | 7 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 2.38e-07 | 195 | 97 | 7 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 195 | 97 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.38e-07 | 195 | 97 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.38e-07 | 195 | 97 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.38e-07 | 195 | 97 | 7 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 195 | 97 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 2.47e-07 | 196 | 97 | 7 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.47e-07 | 196 | 97 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.47e-07 | 196 | 97 | 7 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.47e-07 | 196 | 97 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 2.47e-07 | 196 | 97 | 7 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-07 | 197 | 97 | 7 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 2.55e-07 | 197 | 97 | 7 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.55e-07 | 197 | 97 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.55e-07 | 197 | 97 | 7 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-07 | 197 | 97 | 7 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-07 | 197 | 97 | 7 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.55e-07 | 197 | 97 | 7 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.55e-07 | 197 | 97 | 7 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-07 | 197 | 97 | 7 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.55e-07 | 197 | 97 | 7 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 2.55e-07 | 197 | 97 | 7 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.55e-07 | 197 | 97 | 7 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.64e-07 | 198 | 97 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.64e-07 | 198 | 97 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 2.64e-07 | 198 | 97 | 7 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 2.64e-07 | 198 | 97 | 7 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.64e-07 | 198 | 97 | 7 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 2.64e-07 | 198 | 97 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 2.64e-07 | 198 | 97 | 7 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 2.64e-07 | 198 | 97 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-07 | 198 | 97 | 7 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-07 | 198 | 97 | 7 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 2.73e-07 | 199 | 97 | 7 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 2.73e-07 | 199 | 97 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 2.73e-07 | 199 | 97 | 7 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-07 | 199 | 97 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | severe_influenza-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.73e-07 | 199 | 97 | 7 | 1541f655f7d12c650added3683d07e5417a68dfb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-07 | 199 | 97 | 7 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 2.73e-07 | 199 | 97 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.73e-07 | 199 | 97 | 7 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.73e-07 | 199 | 97 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-07 | 199 | 97 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| Disease | prostate carcinoma | KPNA4 POLR1A EXPH5 RNF213 CCDC178 GPATCH8 DIS3 MAP3K1 CCDC88C SYNE2 PCDH15 DNAH11 | 1.33e-05 | 891 | 88 | 12 | EFO_0001663 |
| Disease | Takayasu Arteritis | 5.26e-05 | 4 | 88 | 2 | C0039263 | |
| Disease | Pituitary Gland Adenoma | 1.31e-04 | 6 | 88 | 2 | EFO_1000478 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.83e-04 | 7 | 88 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | breast carcinoma | NEBL ANKRD26 SMC2 MAP3K1 CCDC88C CEP120 BRCA2 KMT5B ANKRD30A DOT1L DNAH11 | 2.23e-04 | 1019 | 88 | 11 | EFO_0000305 |
| Disease | Malignant neoplasm of breast | KPNA5 KTN1 H6PD MAP3K1 PTPRC BRCA2 SYNE2 ANKRD30A MACF1 NOS2 PLS3 | 3.49e-04 | 1074 | 88 | 11 | C0006142 |
| Disease | cystic kidney disease (implicated_via_orthology) | 3.90e-04 | 10 | 88 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 4.75e-04 | 11 | 88 | 2 | C0265275 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 4.75e-04 | 11 | 88 | 2 | EFO_0009923 | |
| Disease | Short Rib-Polydactyly Syndrome | 6.71e-04 | 13 | 88 | 2 | C0036996 | |
| Disease | Bardet-Biedl Syndrome | 6.71e-04 | 13 | 88 | 2 | C0752166 | |
| Disease | Saldino-Noonan Syndrome | 7.82e-04 | 14 | 88 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 7.82e-04 | 14 | 88 | 2 | C0024507 | |
| Disease | cutaneous melanoma, hair color | 8.54e-04 | 62 | 88 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Dermatitis, Allergic Contact | 1.07e-03 | 67 | 88 | 3 | C0162820 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.12e-03 | 68 | 88 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 1.30e-03 | 550 | 88 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Meckel syndrome type 1 | 1.30e-03 | 18 | 88 | 2 | C3714506 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 2.06e-03 | 766 | 88 | 8 | EFO_0004713, GO_0097366 | |
| Disease | white matter hyperintensity measurement | 2.13e-03 | 302 | 88 | 5 | EFO_0005665 | |
| Disease | pain | 2.85e-03 | 196 | 88 | 4 | EFO_0003843 | |
| Disease | Retinal Diseases | 2.94e-03 | 27 | 88 | 2 | C0035309 | |
| Disease | lissencephaly (implicated_via_orthology) | 2.94e-03 | 27 | 88 | 2 | DOID:0050453 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKAEHMYQNEQDNVD | 1276 | Q9BXX2 | |
| HYTAVQNSKNAKDKN | 26 | Q15078 | |
| QALQEAEKAKHQLNY | 396 | Q96M83 | |
| KPETNQNDTKENHFY | 326 | Q0JRZ9 | |
| KEAEHMYQNEQDNVN | 1296 | Q9BXX3 | |
| LKEKNEEIFNYNNHL | 1366 | Q9BXX3 | |
| DTIKHQNQETENKYF | 576 | A6NC57 | |
| QTKYDADINLLKQEH | 481 | Q8N8E3 | |
| ATHLEIKNYQNDMDN | 991 | Q96DT5 | |
| YNDLIQAQKEISAHN | 561 | Q8TEK3 | |
| NNDNLTYVDEVHKNN | 386 | Q9UPS8 | |
| NHLKERQYQYENEKA | 1201 | Q9UPS8 | |
| AHENALEKQYSEITN | 71 | P0C7W6 | |
| EKVYLCNQDENHKHA | 836 | Q02487 | |
| YALNTKNDEHESAIQ | 56 | Q8NB25 | |
| KLHNAANANQKEKYE | 31 | O75175 | |
| QSHENQEIYQKAFDL | 486 | O15131 | |
| AIQKEDLQKYHNRDT | 96 | Q14644 | |
| ENETKVIKQCYQDHN | 186 | Q92542 | |
| MKVNYEQIVKAHQDN | 211 | Q9UH92 | |
| QDDLQYHNLSKQQNE | 41 | P35228 | |
| FEQHIKNNKDTNKYE | 196 | Q92520 | |
| TYNQNTKEEHQQSKS | 1596 | Q15058 | |
| KLTDIINNDHENVKY | 51 | Q8N335 | |
| EVLKNYNQQKDIEHK | 1546 | Q13439 | |
| KLSKDHDNDNNLYVA | 746 | Q4FZB7 | |
| NMENKEQYHEEQKQY | 1356 | Q9P219 | |
| EQYHEEQKQYIDKLN | 1361 | Q9P219 | |
| KQKSHENQYLEAVND | 406 | Q5BJE1 | |
| FTELNHDQVQKVDQY | 11 | P52789 | |
| CDKQYQKHQEFDNHI | 141 | Q9UKJ3 | |
| NLTEDDKHNNAKYAV | 576 | P13797 | |
| DNFYQHNVEKLENVS | 116 | Q86W56 | |
| TKRQHQKENFQEYTE | 1176 | Q8NEV8 | |
| AVNQQLTKEKEHYQV | 1341 | Q86UP2 | |
| YERIQQKELKSNEDH | 831 | Q9UPP2 | |
| QISEQLNALNKAYHD | 1506 | Q9UPN3 | |
| EKLHQAKEQYEALQE | 3701 | Q9UPN3 | |
| QQKQLDAAINHYIEA | 866 | Q9UG01 | |
| EEYHSDEQNDTQKQL | 466 | A0JP26 | |
| QEDQQDTQIYEKHDN | 536 | P25205 | |
| NTAKVYIEIQDENNH | 1126 | Q96QU1 | |
| YHKRHVETNQQSEKD | 211 | O95976 | |
| KYQEVSQKDSHEQLN | 511 | Q92953 | |
| NKNLQISFNKEHEEN | 311 | Q8NCX0 | |
| DTRYQHKNQQAKIAQ | 1151 | Q5JSL3 | |
| ENDKNHLSEKQDTYL | 1726 | P51587 | |
| IDQLKKENDHYQLQV | 271 | O15078 | |
| HRLQQQLNDAENKYK | 781 | Q8N960 | |
| KRNQQLEAIAKEHYE | 731 | Q8NCU4 | |
| QEHYNKLCNQKTFEE | 376 | Q6ZRK6 | |
| SENVYVNIAHLKNSQ | 146 | P53634 | |
| NKKHCFYQNSDKNEE | 31 | Q56NI9 | |
| DHKNAQAQQEFKNAN | 126 | Q99615 | |
| QHKDENTDIAENLYQ | 71 | Q9NS00 | |
| EQDKIFQGNKDYHQD | 401 | Q96PD2 | |
| KDYRENHNNNKKDHS | 101 | Q9NW75 | |
| DYQALNKDIEAQLQH | 116 | O95479 | |
| NTNELNSNENIHYKL | 516 | Q08AD1 | |
| NLVKHAEVYNQDLEN | 561 | Q02224 | |
| VVNNHQAKQNLYDLD | 171 | Q9BY77 | |
| LQAQLSQKEQAAEHY | 1596 | Q14980 | |
| AENDDTYKDDVNHNQ | 1161 | Q13233 | |
| HQKVYIEDDIKDNSN | 586 | Q8WU17 | |
| KEEVNHYSNEINKAC | 866 | O95602 | |
| AYQNTDITQLKIDHN | 371 | Q16650 | |
| QDENQQLKKIYHEQE | 491 | Q8WXA3 | |
| NYNQNIKAGEKHEKE | 711 | Q8WXH0 | |
| DAQEENLYAAVKHTQ | 526 | Q8NHL6 | |
| EQEHSQKANKISYQS | 336 | P04279 | |
| ALKQHLQDYEKDKEN | 146 | Q5SGD2 | |
| NEEYHSDEQNDTQKQ | 551 | P0CG39 | |
| NQIYEDNDKDAHVQE | 921 | Q562F6 | |
| AIADNNIQDHNVKDF | 121 | Q9BVR0 | |
| IYQIKQQHGEANKEN | 206 | O75934 | |
| YNEHLKKMSADNQLQ | 156 | Q9Y2L1 | |
| EPHKEQYKEFQDLNQ | 616 | Q9Y4F9 | |
| QNEYNAVKEREFHNQ | 131 | Q8IYE0 | |
| VKNDDKIHKQNENFY | 541 | Q86WS4 | |
| EAENVAFANKDQHQL | 2466 | Q63HN8 | |
| NEGKMHEEAYNKLNQ | 121 | A8MXY4 | |
| NNAISKQYHQEIEEF | 101 | Q6NZY4 | |
| EDLKNHYKDILQSCQ | 456 | Q9UNW1 | |
| DHQEKLQLHESQKDY | 251 | Q14247 | |
| EHARLLKNQSQYEKQ | 741 | Q7Z4S6 | |
| KRQNQEVEKENSHFF | 46 | Q15814 | |
| QRTLNELKEYQKQHD | 356 | Q96AE7 | |
| AKYAEVAKHKEQNND | 891 | O95347 | |
| HSEKEKNNLEIDLNY | 661 | Q13464 | |
| DKNKLQAVANQTYHQ | 236 | Q969W1 | |
| AHDNDNLQEQFAKAK | 351 | Q9BZW7 | |
| HQKINENETLYENNE | 236 | Q9UJW8 | |
| EPEQQAYELHQENKK | 941 | Q9UI33 | |
| EQYHSDEQNDTQKQL | 466 | Q6S5H5 | |
| ENEQYHSDEQNDTQK | 501 | Q6S545 | |
| EQYHSDEQNDTQKQL | 466 | A6NI47 | |
| VKKNNHQEDKIEFDN | 1236 | P08575 | |
| QVSAQARQHKLYNKE | 261 | Q9Y4A5 | |
| NNQQDFKYTLIHSEE | 161 | Q7Z570 | |
| EIHDSIVNKNDQNLY | 251 | Q9UKW4 | |
| KIEQLQNHENEDIYK | 461 | O00629 | |
| NQENISSVKYTQDHK | 741 | O76041 |